ATI RN
RN ATI Pharmacology 2019 Exam Questions
Extract:
Question 1 of 5
A nurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?
Correct Answer: C
Rationale: Filgrastim requires refrigeration; leaving it at room temperature for 2 hours risks reduced efficacy, warranting an incident report.
Question 2 of 5
A nurse is providing teaching to a client who is to receive a series of allergy tests. The nurse should instruct the client to avoid which of the following medications for up to 4 weeks before the procedure?
Correct Answer: C
Rationale: Diphenhydramine, an antihistamine, can suppress allergy test results, requiring avoidance for accurate testing.
Question 3 of 5
A nurse is assessing a client who is receiving heparin via continuous IV. The client has an aPTT of 90 seconds. The nurse should monitor the client for which of the following changes in their vital signs?
Correct Answer: D
Rationale: An elevated aPTT indicates increased bleeding risk; an increased pulse rate may signal compensatory response to bleeding.
Question 4 of 5
A nurse is assessing a client who is receiving intravenous therapy. The nurse should identify which of the following findings as a manifestation of fluid volume excess?
Correct Answer: D
Rationale: Distended neck veins indicate fluid volume excess, reflecting increased venous pressure from fluid overload.
Question 5 of 5
A nurse is providing teaching to a client who has a new prescription for bumetanide for heart failure. Which of the following instructions should the nurse include in the teaching?
Correct Answer: B
Rationale: Bumetanide, a loop diuretic, can cause ototoxicity, so monitoring for hearing difficulties is essential.